M K PROTEINS Latest Share Price (MKPL)
TODAY IN ONE LINE
MKPL rose 2.3% on above-average volume (2.8x avg), outperforming Nifty's 1.0% move.
With a market cap of ₹148.27 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
M K PROTEINS flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Earnings DeclineEPS (TTM) has contracted by 54.9% YoY
- ●Sales ContractionQuarterly sales dropped 21.1% YoY
- ●Poor Capital ReturnsLow ROE of 8.9%
- ●Rising Receivables vs SalesReceivables grew 83.8% outpacing sales growth of 9.0%
Latest M K PROTEINS News
What changed recently?
Recent events, corporate actions, and announcements.
M K PROTEINS valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for M K PROTEINS, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
M K PROTEINS technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for M K PROTEINS — derived from the latest tape, not yesterday's close.
M K PROTEINS last traded at ₹3.99 with an intraday range of ₹3.9–₹4.6 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹3.99| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 5.83 | +1.84 | +46.03% |
| R3 | 5.13 | +1.14 | +28.49% |
| R2 | 4.86 | +0.87 | +21.89% |
| R1 | 4.43 | +0.44 | +10.94% |
| PIVOT | 4.16 | 0.17 | 4.34% |
| CURRENT | 3.99 | — | — |
| S1 | 3.73 | -0.26 | -6.60% |
| S2 | 3.46 | -0.53 | -13.20% |
| S3 | 3.03 | -0.96 | -24.14% |
| S4 | 2.33 | -1.66 | -41.69% |
MKPL is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹3.9–₹3.97
Trading Inside opening range
M K PROTEINS financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for M K PROTEINS — consolidated or standalone — with margins, YoY growth and key ratios inline.
M K PROTEINS reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹148.27 Cr. and reported EPS of ₹0.04.
M K PROTEINS segment analysis : revenue and profit mix.
Disclosed business segments at M K PROTEINS with their share of revenue and profit, switchable between consolidated and standalone reporting.
M K PROTEINS discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for M K PROTEINS.
Our AI distills the core fundamental drivers supporting M K PROTEINS, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
M K PROTEINS's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. The security token included in the request is invalid.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
M K PROTEINS peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — M K PROTEINS is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
M K PROTEINS chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for M K PROTEINS — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
M K PROTEINS delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for M K PROTEINS over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in M K PROTEINS stood at 44.3% of traded volume, against a 20-day average of 75.5%.
M K PROTEINS announcements: results, concalls, ratings, M&A.
Filings M K PROTEINS sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
M K PROTEINS files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 58 documents below.
Appointment
M K Proteins Limited has informed the Exchange regarding Appointment of Ms ARITIKA GARG as Non- Executive Independent Director of the company w.e.f.…
Shareholders meeting
M K Proteins Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company…
Shareholders meeting
M K Proteins Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026
Trading Window
M K Proteins Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,…
Copy of Newspaper Publication
Pursuant to the provisions of Regulation 47 of SEBI (LODR) Regulations, 2015, we are submitting newspaper clippings regarding publication of notice…
M K PROTEINS dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue M K PROTEINS has declared, sequenced by announce and record date.
M K PROTEINS corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About M K PROTEINS: business, sector, key facts.
What M K PROTEINS does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
M K PROTEINS operates in the Edible Oil industry under the Fast Moving Consumer Goods sector, listed as NSE: MKPL, BSE: 543919.
M. K. Proteins Limited (MKPL) is primarily engaged in the manufacturing and trading of vegetable refined oils and their associated by-products. Their operations span a wide range of vegetable oils, including rice bran, sunflower, cottonseed, soybean, palm, and canola oils. The company's core business revolves around processing these oils into refined products suitable for various applications, from culinary use to industrial purposes.
A significant aspect of MKPL's business model is the utilization of oil by-products. Instead of discarding these materials, the company processes them into valuable secondary products. This includes extracting and selling rice bran fatty acid oils, rice bran waxes, gums, and spent earth. This vertical integration strategy maximizes resource utilization and contributes to a more efficient and sustainable business operation.
Beyond its refining and processing capabilities, MKPL also plays a crucial role in the import and trade of crude oils. This involvement in the global oil market allows the company to secure raw materials and manage its supply chain effectively. The company's trading activities extend to both edible and non-edible oils, further diversifying its revenue streams and market reach.
In summary, MKPL's business encompasses the entire value chain from sourcing crude oils to refining them, creating valuable by-products, and finally, trading both refined and crude oils in the market. This integrated approach to oil processing and trading positions the company within a robust and diversified market segment within India’s edible oil industry. The company’s focus on utilizing by-products also demonstrates an understanding of sustainable practices and resource management. Established in 2012 and headquartered in Ambala, India, MKPL has carved a niche for itself in the Indian vegetable oil market.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AWL AGRI BUSINESS (AWL) Share PricePeer
- GOKUL REFOILS & SOLV (GOKUL) Share PricePeer
- GOKUL AGRO RESOURCES (GOKULAGRO) Share PricePeer
- KRITI NUTRIENTS (KRITINUT) Share PricePeer
- MARICO (MARICO) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about M K PROTEINS (MKPL).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of M K PROTEINS (MKPL)?
The current share price of M K PROTEINS (MKPL) is ₹3.99. Today, the stock has gained by ₹0.09 (2.31%), trading in a range of ₹3.90 to ₹4.60. The stock opened at ₹3.97 with a trading volume of 3,59,653 shares.
02Is M K PROTEINS stock a good investment for long-term?
M K PROTEINS can be considered for long-term investment based on several factors. The company has a market capitalization of ₹148.27 Cr., P/E ratio of 0, ROE of 8.95%, and ROCE of 7.3%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of M K PROTEINS stock?
The 52-week high price of M K PROTEINS (MKPL) is ₹7.31, while the 52-week low is ₹3.56. Currently trading at ₹3.99, the stock is 12.08% above its 52-week low and 45.42% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy M K PROTEINS stock at the current price?
Whether to buy M K PROTEINS stock at ₹3.99 depends on multiple factors. The stock is currently trading with a P/E ratio of 0 and P/B ratio of 0. Today's performance shows a gain of 2.31%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of M K PROTEINS and when is the next dividend?
M K PROTEINS offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹3.99, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of M K PROTEINS?
M K PROTEINS's key financial metrics include: P/E Ratio: 0, P/B Ratio: 0, ROE: 8.95%, ROCE: 7.3%, Dividend Yield: 0%, EPS: ₹0.04, Book Value: ₹2.03, and Debt-to-Equity: 0.47. The company's market cap stands at ₹148.27 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is M K PROTEINS stock performing today in the market?
M K PROTEINS stock opened at ₹3.97 and is currently trading at ₹3.99, showing a gain of ₹0.09 (2.31%). The intraday high is ₹4.60 and low is ₹3.90. The trading volume stands at 3,59,653 shares, indicating moderate market participation today.
08What is the P/E ratio of M K PROTEINS and what does it indicate?
M K PROTEINS has a Price-to-Earnings (P/E) ratio of 0, which means investors are willing to pay 0.00 for every ₹1 of earnings. With an EPS of ₹0.04, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about M K PROTEINS (MKPL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.